Wikisage, the free encyclopedia of the second generation, is digital heritage
Memantine: Difference between revisions
Jump to navigation
Jump to search
(Created page with "Memantine is a non competitive NMDA-R antagonist, with serotoninergic 5HT3-R dopaminergic D2-R and cholinergic maCH-R and nACH-R antagonism, used to control acquired pendular...") |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Memantine is a non competitive NMDA-R antagonist, with serotoninergic | Memantine is a non competitive NMDA-R antagonist, with serotoninergic 5HT<sub>3</sub>-R dopaminergic D<sub>2</sub>-R and cholinergic maCHh-R and nACh-R antagonism, used to control acquired pendular nystagmus | ||
<ref>Soto E and Rosario Vega [[2010]] Neuropharmacology of vestibular system disorders Current Neuropharmacology 8: 26-40 | <ref>Soto E and Rosario Vega [[2010]] Neuropharmacology of vestibular system disorders Current Neuropharmacology 8: 26-40 | ||
</ref> | </ref> | ||
{{Wikidata|Q412189}} | |||
<references/> | <references/> | ||
Latest revision as of 00:14, 7 May 2019
Memantine is a non competitive NMDA-R antagonist, with serotoninergic 5HT3-R dopaminergic D2-R and cholinergic maCHh-R and nACh-R antagonism, used to control acquired pendular nystagmus [1]
